Welcome to FIT Biotech’s investor pages!

These pages give you background about FIT Biotech as an investment.

Our mission is to provide Finnish biotechnology for international medical treatment.

Our strategy focuses on licensing our patented GTU® (Gene Transport Unit) technology to partners for medical applications, in particular for applications with high commercial potential targeted at existing large markets or markets with a need for more efficient, safer and less costly treatments.